Henry Brem

Henry Brem

Director/Board Member at GALECTIN THERAPEUTICS INC.

Net worth: - $ as of 31/05/2026

73 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Henry Brem, MD, is an Independent Director at Galectin Therapeutics, Inc. and a Venture Partner at Catalio Capital Management LP.
He is on the Board of Directors at Galectin Therapeutics, Inc., CraniUS LLC, Galen Robotics, Inc. and LikeMinds, Inc. (Massachusetts).
Dr. Brem was previously employed as a Co- Founder by Focal, Inc. He also served on the board at Alseres Pharmaceuticals, Inc. and Maryland / Israel Development Center.
He received his undergraduate degree from New York University and a doctorate degree from Harvard University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
12/03/2026 0 ( -.--% ) - $ 31/05/2026

Henry Brem active positions

CompaniesPositionStart
GALECTIN THERAPEUTICS INC. Director/Board Member 12/03/2026
Director/Board Member -
Director/Board Member -
Private Equity Investor -
Director/Board Member -

Former positions of Henry Brem

CompaniesPositionEnd
ALSERES PHARMACEUTICALS, INC. Director/Board Member 08/01/2010
Founder -
Director/Board Member -
See the detail of Henry Brem's experience

Training of Henry Brem

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

96

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Process Industries

Health Technology

Consumer Services

Consumer Services

Commercial Services

Distribution Services

Commercial Services

Finance

Health Technology

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!